Skip to content

Abacavir matches tenofovir in Canadian patients with high viral load

Some older HIV drugs linked to premature ageing

Abacavir and cardiovascular risk: contradictory findings continue to emerge, mechanisms still unclear

Switch from efavirenz to raltegravir improves mood and lipid profiles

Rilpivirine (Edurant) approved in United States

Some London clinics may have difficulty meeting drug prescription targets

High rate of liver fibrosis progression in HIV-positive patients, but signs that earlier initiation of antiretrovirals protective

Atazanavir associated with significant risk of kidney stones and renal impairment

Large study shows that abacavir doesn't increase short or long-term risk of heart attack